INGENIOUS PERSONALIZED MEDICINE, LLC
NPI 1598161846
Clinical Medical Laboratory in North Miami, FL
NPI Status: Active since November 14, 2014
Contact Information
1065 NE 125TH STREET
SUITE 217
NORTH MIAMI, FL
ZIP 33161
Phone: (786) 221-1734
Fax: (305) 891-4228
- Organization
- Clinical Medical Laboratory
About INGENIOUS PERSONALIZED MEDICINE, LLC
This page provides the complete NPI Profile along with additional information for Ingenious Personalized Medicine, Llc, a provider established in North Miami, Florida operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1598161846 assigned on November 2014. The practitioner's primary taxonomy code is 291U00000X. The provider is registered as an organization and their NPI record was last updated 4 years ago. The authorized official of this NPI record is Dr. Scott Segal Md (Ceo/ President)
- NPI
- 1598161846
- Provider Name
- INGENIOUS PERSONALIZED MEDICINE, LLC
- Entity Type
- Organization
- Location Address
- 1065 NE 125TH STREET SUITE 217 NORTH MIAMI, FL 33161
- Location Phone
- (786) 221-1734
- Location Fax
- (305) 891-4228
- Mailing Address
- 1065 NE 125TH STREET SUITE 300 NORTH MIAMI, FL 33161
- Mailing Phone
- (786) 221-1734
- Mailing Fax
- (305) 891-4228
- Is Sole Proprietor?
- No
- Is Organization Subpart?
- No
- Enumeration Date
- 11-14-2014
- Last Update Date
- 06-02-2021
- Code Navigator
Establishments like Ingenious Personalized Medicine, Llc are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.
Location Map
Secondary Locations
- 6915 Tutt Blvd #110A
Colorado Springs, CO 80923
(303) 802-3474
Specialty - Primary Taxonomy
The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.
- Classification
Clinical Medical Laboratory
- Taxonomy Code
- 291U00000X
- Type
- Laboratories
- Taxonomy Description
- (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.
Areas of Expertise
The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source
Testing for presence of drug, by chemistry analyzers
A definitive drug test is a detailed examination that can identify specific drugs in your system, even closely related ones. Techniques like GC/MS and LC/MS are used for high precision. This helps ensure accurate results for your safety and health.
This service was performed 128 times for 120 patientsA definitive drug test is a detailed analysis used to identify specific drugs in your system. It uses advanced techniques, such as gc/ms and lc/ms, to detect and distinguish between different drugs, even those with similar structures.
This service was performed 38 times for 37 patientsThis is a test to detect the COVID-19 virus. It uses a technique that amplifies the virus's genetic material (DNA or RNA) for detection. High throughput technologies are used for rapid and large-scale testing. The procedure is completed within a set time frame.
This service was performed 1,874 times for 1,544 patientsThis is a test for COVID-19. It uses high-tech methods to find the virus's genetic material in your body. The amplified probe technique helps detect the virus even in small amounts. This is crucial for early detection and effective treatment.
This service was performed 1,875 times for 1,545 patientsSpecimen collection for SARS-CoV-2, the virus causing COVID-19, involves taking a sample from the nose or throat using a swab. This sample is then analyzed in a lab to detect the presence of the virus. It's a crucial step in diagnosing COVID-19.
This service was performed 1,247 times for 1,027 patientsChemistry analyzers are used to detect the presence of drugs in your system. This test involves taking a small sample of your blood or urine. The sample is then analyzed for specific substances. The results help in understanding your health condition better.
This service was performed 156 times for 129 patientsReviews for INGENIOUS PERSONALIZED MEDICINE, LLC
There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.
NPI Validation Check Digit Calculation
The following table explains the step by step NPI number validation process using the ISO standard Luhn algorithm.
| Start with the original NPI number, the last digit is the check digit and is not used in the calculation. | |||||||||
| 1 | 5 | 9 | 8 | 1 | 6 | 1 | 8 | 4 | 6 |
| Step 1: Double the value of the alternate digits, beginning with the rightmost digit. | |||||||||
| 2 | 5 | 18 | 8 | 2 | 6 | 2 | 8 | 8 | |
| Step 2: Add all the doubled and unaffected individual digits from step 1 plus the constant number 24. | |||||||||
| 2 + 5 + 1 + 8 + 8 + 2 + 6 + 2 + 8 + 8 + 24 = 74 | |||||||||
| Step 3: Subtract the total obtained in step 2 from the next higher number ending in zero, the result is the check digit. | |||||||||
| 80 - 74 = 6 | 6 | ||||||||
The NPI number 1598161846 is valid because the calculated check digit 6 using the Luhn validation algorithm matches the last digit of the original NPI number.
Other Providers at the Same Location
The following 2 providers are registered at the same or nearby location.
| NPI | Name / Type | Taxonomy | Address |
|---|---|---|---|
| 1043208598 | JOEL ROBERT SAVITCH ARNP Individual | Nurse Practitioner (Gerontology) | 1065 NE 125TH STREET SUITE 206 NORTH MIAMI, FL 33161 (305) 891-0050 |
| 1376902270 | PAOLA C LEY Individual | Contractor | 1065 NE 125TH STREET SUITE 300 NORTH MIAMI, FL 33161 (786) 221-0908 |
Frequently Asked Questions
The NPI number assigned to this healthcare provider is 1598161846, enumerated in the NPI registry as an "organization" on November 14, 2014
The provider is located at 1065 Ne 125th Street Suite 217 North Miami, Fl 33161 and the phone number is (786) 221-1734
This medical organization specializes in Clinical Medical Laboratory with taxonomy code 291U00000X
The most common procedures or services performed by this practitioner are: Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r, Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source and Testing for presence of drug, by chemistry analyzers.
This NPI record was last updated on November 14, 2014. To officially update your NPI information contact the National Plan and Provider Enumeration System (NPPES) at 1-800-465-3203 (NPI Toll-Free) or by email at [email protected].
NPI Profile data is regularly updated with the latest NPI registry information, if you would like to update or remove your NPI Profile in this website please contact us.